---
title: "BillionToOne Chief Product Officer Sakakibara Shan Riku disposes of 4,000 common shares worth $560,840"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294868285.md"
description: "BillionToOne Chief Product Officer Sakakibara Shan Riku sold 4,000 Class A common shares on July 31, 2026, at $140.21 per share, totaling $560,840. Following this transaction, his stake decreased to 200,000 shares."
datetime: "2026-08-04T20:34:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294868285.md)
  - [en](https://longbridge.com/en/news/294868285.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294868285.md)
generator: "portal-rs"
---

# BillionToOne Chief Product Officer Sakakibara Shan Riku disposes of 4,000 common shares worth $560,840

-   BillionToOne Chief Product Officer Sakakibara Shan Riku sold 4,000 Class A common shares on July 31, 2026 at USD 140.21. \* Stake fell to 200,000 shares following the transaction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Billiontoone Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002088547-26-000008), on August 04, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [BLLN.US](https://longbridge.com/en/quote/BLLN.US.md)

## Related News & Research

- [BillionToOne management to join Wells Fargo Annual Healthcare Conference fireside chat](https://longbridge.com/en/news/297824047.md)
- [BillionToOne SVP Laboratory Operations John Roderick ten Bosch sells 1,417 Class A shares for $141,700](https://longbridge.com/en/news/297244692.md)
- [Damartex reports FY2025-26 annual results release available](https://longbridge.com/en/news/298344100.md)
- [Vivos Therapeutics amends 8-K to correct report date to Sept. 2, 2026](https://longbridge.com/en/news/298368513.md)
- [Baozun reports 187,585,241 total issued shares at Aug. 31, 2026 monthly close](https://longbridge.com/en/news/297895620.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**